Entero Healthcare Solutions has successfully completed the acquisition of a majority equity stake (51.51%) in Anand Chemiceutics Private Limited. This announcement follows a prior intimation on November 12, 2025, regarding the company’s intention to acquire the stake. The completed acquisition marks a strategic move for Entero Healthcare, further solidifying its position in the healthcare solutions market.
Acquisition Completion
Entero Healthcare Solutions has finalized its acquisition of a majority stake in Anand Chemiceutics Private Limited. The deal, securing 51.51% of equity, was officially completed as of February 7, 2026.
Prior Announcement
The initial notification regarding this acquisition was released on November 12, 2025. All details regarding the acquisition were previously furnished as per regulatory requirements in the earlier communication.
Strategic Rationale
This acquisition is expected to contribute positively to Entero Healthcare Solutions’ growth strategy. By integrating Anand Chemiceutics, Entero strengthens its portfolio within the healthcare sector and anticipates synergistic benefits from the combined operations.
Source: BSE
